Cardiol Therapeutics
(NASDAQ:CRDL)
$1.75
-0.01[-0.57%]
At close: Apr 23
$1.75
0[0.00%]
PreMarket: 6:46PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Cardiol Therapeutics Stock (NASDAQ:CRDL), Quotes and News Summary

Cardiol Therapeutics Stock (NASDAQ: CRDL) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 391.801K
Day Range- - -
52 Wk Range0.550 - 2.170
Market Cap$119.470M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
50
Short Interest
0.5%
Days to Cover1.02

Recent News

Sponsored
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations
697,000 people die from heart disease every year in the United States – that is one in every five deaths.
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in Cardiol's novel CRD-38 subcutaneous (SUBQ) formulati
Jelena Martinovic
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clini...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRDL

FAQ

Q

How do I buy Cardiol Therapeutics (CRDL) stock?

A

You can purchase shares of Cardiol Therapeutics (NASDAQ: CRDL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cardiol Therapeutics's (CRDL) competitors?

A

There are no as such competitors for Cardiol Therapeutics.

Q

What is the target price for Cardiol Therapeutics (CRDL) stock?

A

The latest price target for Cardiol Therapeutics (NASDAQ: CRDL) was reported by HC Wainwright & Co. on Monday, April 22, 2024. The analyst firm set a price target for 9.00 expecting CRDL to rise to within 12 months (a possible 414.29% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cardiol Therapeutics (CRDL)?

A

The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.75 last updated April 23, 2024 at 6:46 PM EDT.

Q

Does Cardiol Therapeutics (CRDL) pay a dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Cardiol Therapeutics (CRDL) going to split?

A

There is no upcoming split for Cardiol Therapeutics.

Q

What sector and industry does Cardiol Therapeutics (CRDL) operate in?

A

Cardiol Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.